Skip to content

Clinical trials

Completed Immunoglobulin Light-chain Amyloidosis trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoglobulin Light-chain Amyloidosis Phase: Not applicable Status: Completed Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20062
20101
20111
20121
20181
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center2
Wake Forest University Health Sciences2
Fondazione IRCCS Policlinico San Matteo di Pavia1
GCS Ramsay Santé pour l'Enseignement et la Recherche1
Jian Li1
Massachusetts General Hospital1
Memorial Sloan Kettering Cancer Center1
Roswell Park Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoglobulin Light-chain Amyloidosis10
Leukemia, Lymphocytic, Chronic, B-Cell6
Multiple Myeloma6
Precursor Cell Lymphoblastic Leukemia-Lymphoma6
Burkitt Lymphoma5
Hodgkin Disease5
Lymphoma, Large B-Cell, Diffuse5
Lymphoma, Large-Cell, Anaplastic5
Lymphoma, Non-Hodgkin5
Lymphoma, T-Cell, Cutaneous5

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.